Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Edward C. Tocus"'
Publikováno v:
Journal of Psychoactive Drugs. 15:151-157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd4d8efea8713054829edb864f04fe7a
https://doi.org/10.1080/02791072.1983.10472136
https://doi.org/10.1080/02791072.1983.10472136
Publikováno v:
Cancer. 15:153-159
The efficiency of I/sup 131/-labeled, octoiodofluorescein (OIF-I/sup 131/ ) as an agent for localizing human brain tumors in situ was investigatod using a manually operated scanning device. The dye was found to produce no toxic symptoms in total dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::445d508401b44350b5aca9527e4782df
https://doi.org/10.1002/1097-0142(196201/02)15:1<153::aid-cncr2820150121>3.0.co
https://doi.org/10.1002/1097-0142(196201/02)15:1<153::aid-cncr2820150121>3.0.co
Publikováno v:
The International Journal of Applied Radiation and Isotopes. 7:273-286
The majority of carbon compounds of metabolic interest ultimately are degraded to carbon dioxide and urea which are excreted. Following the administration of a tracer dose of a C/sup 14/-labeled metabolite, there is assumed to be a pattern of elimina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16f1ac0250362167c89c355b553d3abc
https://doi.org/10.1016/0020-708x(60)90116-2
https://doi.org/10.1016/0020-708x(60)90116-2
Autor:
Edward C. Tocus
Publikováno v:
Controlled Clinical Trials. 5:463-465
Three basic principles must be satisfied when a substance is being considered for human ingestion: 1. 1. The composition of the product must be consistent within certain limits over a specific period of time. 2. 2. It must not produce irreversible ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038e5f7e87d90981efca4fab810e7281
https://doi.org/10.1016/0197-2456(84)90004-7
https://doi.org/10.1016/0197-2456(84)90004-7
Autor:
Edward C. Tocus
Publikováno v:
Endorphins in Mental Health Research ISBN: 9781349040179
This chapter will discuss the conditions which the U.S. Food and Drug Administration (FDA) will require for the study of the endorphins in man.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a89ce1004864306223e452b96906656a
https://doi.org/10.1007/978-1-349-04015-5_45
https://doi.org/10.1007/978-1-349-04015-5_45
